Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124994025> ?p ?o ?g. }
- W2124994025 endingPage "802" @default.
- W2124994025 startingPage "794" @default.
- W2124994025 abstract "Renin–angiotensin and endothelin systems are involved in the cardiovascular effects produced by treatment with ouabain. We recently demonstrated that the contractile response to phenylephrine is decreased in ouabain‐treated rats. The present study investigated whether endothelin‐1 (ET‐1) and angiotensin II (Ang II) contributes to the vascular changes observed in rats chronically treated with ouabain. Wistar rats were treated with ouabain (8.0 μ g day −1 , s.c. pellets for 5 weeks) alone or in combination with an endothelin type A receptor (ET A ) antagonist, BMS182874 (40 mg kg −1 day −1 , per gavage) or an angiotensin type 1 (AT 1 ) receptor antagonist, losartan (15 mg kg −1 day −1 , p.o.). Treatment with ouabain increased systolic blood pressure and treatment with either losartan or BMS182874 prevented the development of ouabain‐induced hypertension. The sensitivity and maximal response for phenylephrine were reduced in aortic rings from ouabain‐treated rats. Removal of the endothelium or in vitro exposure to an inhibitor of nitric oxide synthase (NOS), N ‐nitro‐ L ‐arginine methyl ester ( L ‐NAME, 100 μ M ) increased the responses to phenylephrine, an effect that was more pronounced in aortas from ouabain‐treated rats. Endothelial NOS protein (eNOS) expression was increased after ouabain treatment. Treatment with BMS182874, but not with losartan, prevented the effects of ouabain on the reactivity of phenylephrine and in eNOS protein expression. Gene expression of pre–pro‐ET‐1 and ET A receptors was increased in aortic rings from ouabain‐treated rats. ET B receptor gene expression was not altered by ouabain treatment. In conclusion, our results suggest that endothelin and angiotensin systems play an important role in the development of ouabain‐induced hypertension. However, ET‐1, by activation of ET A receptors, but not Ang II, contributes to changes in vascular reactivity to phenylephrine induced by chronic treatment with ouabain. British Journal of Pharmacology (2004) 143 , 794–802. doi: 10.1038/sj.bjp.0705994" @default.
- W2124994025 created "2016-06-24" @default.
- W2124994025 creator A5011901374 @default.
- W2124994025 creator A5015967445 @default.
- W2124994025 creator A5048180552 @default.
- W2124994025 creator A5050059516 @default.
- W2124994025 creator A5062660706 @default.
- W2124994025 creator A5073503543 @default.
- W2124994025 creator A5081286367 @default.
- W2124994025 creator A5084241764 @default.
- W2124994025 date "2004-11-01" @default.
- W2124994025 modified "2023-10-15" @default.
- W2124994025 title "Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain" @default.
- W2124994025 cites W1672412245 @default.
- W2124994025 cites W1687906556 @default.
- W2124994025 cites W1965672183 @default.
- W2124994025 cites W1968382041 @default.
- W2124994025 cites W1970260922 @default.
- W2124994025 cites W1977043280 @default.
- W2124994025 cites W1977703364 @default.
- W2124994025 cites W1982255713 @default.
- W2124994025 cites W1983117113 @default.
- W2124994025 cites W1990545419 @default.
- W2124994025 cites W1997819382 @default.
- W2124994025 cites W2008338314 @default.
- W2124994025 cites W2011348280 @default.
- W2124994025 cites W2017510117 @default.
- W2124994025 cites W2022709209 @default.
- W2124994025 cites W2044261371 @default.
- W2124994025 cites W2047390875 @default.
- W2124994025 cites W2068472733 @default.
- W2124994025 cites W2078205845 @default.
- W2124994025 cites W2084836815 @default.
- W2124994025 cites W2110872078 @default.
- W2124994025 cites W2111696392 @default.
- W2124994025 cites W2117422642 @default.
- W2124994025 cites W2127664784 @default.
- W2124994025 cites W2131118406 @default.
- W2124994025 cites W2137307314 @default.
- W2124994025 cites W2142074982 @default.
- W2124994025 cites W2152754031 @default.
- W2124994025 cites W2153826418 @default.
- W2124994025 cites W2168929324 @default.
- W2124994025 cites W2274187082 @default.
- W2124994025 cites W2286821725 @default.
- W2124994025 cites W2315190103 @default.
- W2124994025 cites W2331525932 @default.
- W2124994025 cites W2411784760 @default.
- W2124994025 cites W2417677906 @default.
- W2124994025 cites W4239489354 @default.
- W2124994025 doi "https://doi.org/10.1038/sj.bjp.0705994" @default.
- W2124994025 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1575934" @default.
- W2124994025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15477225" @default.
- W2124994025 hasPublicationYear "2004" @default.
- W2124994025 type Work @default.
- W2124994025 sameAs 2124994025 @default.
- W2124994025 citedByCount "23" @default.
- W2124994025 countsByYear W21249940252012 @default.
- W2124994025 countsByYear W21249940252013 @default.
- W2124994025 countsByYear W21249940252014 @default.
- W2124994025 countsByYear W21249940252016 @default.
- W2124994025 countsByYear W21249940252021 @default.
- W2124994025 countsByYear W21249940252022 @default.
- W2124994025 countsByYear W21249940252023 @default.
- W2124994025 crossrefType "journal-article" @default.
- W2124994025 hasAuthorship W2124994025A5011901374 @default.
- W2124994025 hasAuthorship W2124994025A5015967445 @default.
- W2124994025 hasAuthorship W2124994025A5048180552 @default.
- W2124994025 hasAuthorship W2124994025A5050059516 @default.
- W2124994025 hasAuthorship W2124994025A5062660706 @default.
- W2124994025 hasAuthorship W2124994025A5073503543 @default.
- W2124994025 hasAuthorship W2124994025A5081286367 @default.
- W2124994025 hasAuthorship W2124994025A5084241764 @default.
- W2124994025 hasBestOaLocation W21249940252 @default.
- W2124994025 hasConcept C126322002 @default.
- W2124994025 hasConcept C134018914 @default.
- W2124994025 hasConcept C144980905 @default.
- W2124994025 hasConcept C149601957 @default.
- W2124994025 hasConcept C170493617 @default.
- W2124994025 hasConcept C178790620 @default.
- W2124994025 hasConcept C185592680 @default.
- W2124994025 hasConcept C198710026 @default.
- W2124994025 hasConcept C2777622882 @default.
- W2124994025 hasConcept C2777952589 @default.
- W2124994025 hasConcept C2778326061 @default.
- W2124994025 hasConcept C2779133857 @default.
- W2124994025 hasConcept C2780288358 @default.
- W2124994025 hasConcept C2908929049 @default.
- W2124994025 hasConcept C519581460 @default.
- W2124994025 hasConcept C537181965 @default.
- W2124994025 hasConcept C71924100 @default.
- W2124994025 hasConcept C84393581 @default.
- W2124994025 hasConceptScore W2124994025C126322002 @default.
- W2124994025 hasConceptScore W2124994025C134018914 @default.
- W2124994025 hasConceptScore W2124994025C144980905 @default.
- W2124994025 hasConceptScore W2124994025C149601957 @default.
- W2124994025 hasConceptScore W2124994025C170493617 @default.
- W2124994025 hasConceptScore W2124994025C178790620 @default.